Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
24.50
-0.20 (-0.81%)
At close: Apr 25, 2025, 4:00 PM HKT
-12.50%
Market Cap 4.42B
Revenue (ttm) n/a
Net Income (ttm) -179.03M
Shares Out 200.99M
EPS (ttm) -0.89
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 163,070
Open 24.50
Previous Close 24.70
Day's Range 24.50 - 24.50
52-Week Range 19.00 - 28.30
Beta n/a
RSI 21.28
Earnings Date May 21, 2025

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection product for the treatment of various autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylit... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 159
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2480
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.